FDA Approves First Drug, Emgality (Galcanezumab-gnlm), to Help Tame Cluster Headaches

WEDNESDAY, June 5, 2019 — The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that’s the first to cut the frequency of cluster headaches.
Episodic cluster headaches are “an extremely painful and often…
Source: Topamax